Trademark Snap Shot Publication Stylesheet (Table presents the data on Publication Approval) |
|||
OVERVIEW |
|||
SERIAL NUMBER | 76434613 | FILING DATE | 07/25/2002 |
REG NUMBER | 0000000 | REG DATE | N/A |
REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
INTL REG # | N/A | INTL REG DATE | N/A |
TM ATTORNEY | DALIER, JOHN DAVID |
L.O. ASSIGNED | 106 |
PUB INFORMATION |
|||
RUN DATE | 04/19/2006 | ||
PUB DATE | 01/07/2003 | ||
STATUS | 818-SU - STATEMENT OF USE ACCEPTED - APPROVED FOR REGISTRATION | ||
STATUS DATE | 04/18/2006 | ||
LITERAL MARK ELEMENT | BIOENVISION | ||
DATE ABANDONED | N/A | DATE CANCELLED | N/A |
SECTION 2F | NO | SECTION 2F IN PART | NO |
SECTION 8 | NO | SECTION 8 IN PART | NO |
SECTION 15 | NO | REPUB 12C | N/A |
RENEWAL FILED | NO | RENEWAL DATE | N/A |
DATE AMEND REG | N/A |
FILING BASIS |
|||||
FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
1 (a) | NO | 1 (a) | YES | 1 (a) | NO |
1 (b) | YES | 1 (b) | NO | 1 (b) | NO |
44D | NO | 44D | NO | 44D | NO |
44E | NO | 44E | NO | 44E | NO |
66A | NO | 66A | NO | ||
NO BASIS | NO | NO BASIS | NO |
MARK DATA |
|
STANDARD CHARACTER MARK | NO |
LITERAL MARK ELEMENT | BIOENVISION |
MARK DRAWING CODE | 1-TYPESET WORD(S)/LETTER(S)/NUMBER(S) |
COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
PARTY TYPE | 20-OWNER AT PUBLICATION |
NAME | BIOENVISION INC. |
ADDRESS | 345 Park Avenue, 41st Floor New York, NY 101540001 |
ENTITY | 03-CORPORATION |
CITIZENSHIP | Delaware |
GOODS AND SERVICES |
|
INTERNATIONAL CLASS | 005 |
DESCRIPTION TEXT | PHARMACEUTICALS, NAMELY THERAPEUTIC DRUGS ADMINISTERED IN THE TREATMENT OF CANCER AND AUTOIMMUNE DISEASES |
GOODS AND SERVICES CLASSIFICATION |
|||||||
INTERNATIONAL CLASS | 005 | FIRST USE DATE | 10/00/2003 | FIRST USE IN COMMERCE DATE | 10/00/2004 | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
CHANGE IN REGISTRATION | NO |
PSEUDO MARK | BIO ENVISION |
PROSECUTION HISTORY |
||||
DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
04/18/2006 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 033 |
04/01/2006 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | 032 |
03/16/2006 | IUAF | S | USE AMENDMENT FILED | 031 |
03/16/2006 | EISU | I | TEAS STATEMENT OF USE RECEIVED | 030 |
03/16/2006 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | 029 |
03/01/2006 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 028 |
02/07/2006 | I | PAPER RECEIVED | 027 | |
09/29/2005 | UNDN | O | UNDELIVERABLE MAIL - NO ACTION TAKEN | 026 |
09/19/2005 | I | PAPER RECEIVED | 025 | |
09/08/2005 | EX5G | S | EXTENSION 5 GRANTED | 024 |
09/08/2005 | EXT5 | S | EXTENSION 5 FILED | 023 |
09/08/2005 | EEXT | I | TEAS EXTENSION RECEIVED | 022 |
07/06/2005 | UNDN | O | UNDELIVERABLE MAIL - NO ACTION TAKEN | 021 |
04/22/2005 | I | PAPER RECEIVED | 020 | |
03/29/2005 | EX4G | S | EXTENSION 4 GRANTED | 019 |
03/04/2005 | EXT4 | S | EXTENSION 4 FILED | 018 |
03/04/2005 | EEXT | I | TEAS EXTENSION RECEIVED | 017 |
10/05/2004 | EX3G | S | EXTENSION 3 GRANTED | 016 |
09/22/2004 | EXT3 | S | EXTENSION 3 FILED | 015 |
09/22/2004 | EEXT | I | TEAS EXTENSION RECEIVED | 014 |
08/11/2004 | CFIT | O | CASE FILE IN TICRS | 013 |
03/18/2004 | I | PAPER RECEIVED | 012 | |
03/11/2004 | EX2G | S | EXTENSION 2 GRANTED | 011 |
03/11/2004 | EXT2 | S | EXTENSION 2 FILED | 010 |
03/11/2004 | EEXT | I | TEAS EXTENSION RECEIVED | 009 |
12/16/2003 | EX1G | S | EXTENSION 1 GRANTED | 008 |
07/14/2003 | EXT1 | S | EXTENSION 1 FILED | 007 |
07/16/2003 | I | PAPER RECEIVED | 006 | |
04/01/2003 | NOAM | O | NOTICE OF ALLOWANCE-MAILED | 005 |
01/07/2003 | PUBO | A | PUBLISHED FOR OPPOSITION | 004 |
12/18/2002 | NPUB | O | NOTICE OF PUBLICATION | 003 |
10/28/2002 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 002 |
10/24/2002 | DOCK | D | ASSIGNED TO EXAMINER | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
ATTORNEY | Constance Golden |
CORRESPONDENCE ADDRESS | Constance Golden Abelman Frayne & Schwab 10th Floor 666 Third Avenue New York NY 10017 |
DOMESTIC REPRESENTATIVE | NONE |
PRIOR OWNER INFORMATION |
|
PARTY TYPE | 10-ORIGINAL APPLICANT |
NAME | BIOENVISION INC. |
ADDRESS | 1 Rockefeller Center, Suite 1600 New York, NY 10020 |
ENTITY | 03-CORPORATION |
CITIZENSHIP | Delaware |